These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 38777821)

  • 21. Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes.
    Chambers E; Mitragotri S
    J Control Release; 2004 Nov; 100(1):111-9. PubMed ID: 15491815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a fluorescence-based in vivo phagocytosis assay to measure mononuclear phagocyte system function in the rat.
    Tartaro K; VanVolkenburg M; Wilkie D; Coskran TM; Kreeger JM; Kawabata TT; Casinghino S
    J Immunotoxicol; 2015; 12(3):239-46. PubMed ID: 25027674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Charge-Switchable nanoparticles to enhance tumor penetration and accumulation.
    Souri M; Golzaryan A; Soltani M
    Eur J Pharm Biopharm; 2024 Jun; 199():114310. PubMed ID: 38705311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Study of Nanoparticle Blood Circulation after Forced Clearance of Own Erythrocytes (Mononuclear Phagocyte System-Cytoblockade) or Administration of Cytotoxic Doxorubicin- or Clodronate-Loaded Liposomes.
    Mochalova EN; Egorova EA; Komarova KS; Shipunova VO; Khabibullina NF; Nikitin PI; Nikitin MP
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Advances in Nanotechnology with Nano-Phytochemicals: Molecular Mechanisms and Clinical Implications in Cancer Progression.
    Kim B; Park JE; Im E; Cho Y; Lee J; Lee HJ; Sim DY; Park WY; Shim BS; Kim SH
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.
    Suk JS; Xu Q; Kim N; Hanes J; Ensign LM
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):28-51. PubMed ID: 26456916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Fate of Nanoparticles In Vivo and the Strategy of Designing Stealth Nanoparticle for Drug Delivery.
    Bao J; Zhang Q; Duan T; Hu R; Tang J
    Curr Drug Targets; 2021; 22(8):922-946. PubMed ID: 33461465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and screening studies of the interaction between mononuclear phagocyte system and nanoparticle formulations and colloid forming drugs.
    Lucas AT; Herity LB; Kornblum ZA; Madden AJ; Gabizon A; Kabanov AV; Ajamie RT; Bender DM; Kulanthaivel P; Sanchez-Felix MV; Havel HA; Zamboni WC
    Int J Pharm; 2017 Jun; 526(1-2):443-454. PubMed ID: 28473237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation and heterogeneity in the mononuclear phagocyte system.
    Hume DA
    Mucosal Immunol; 2008 Nov; 1(6):432-41. PubMed ID: 19079210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein Nanoparticle Fabrication for Optimized Reticuloendothelial System Evasion and Tumor Accumulation.
    Roh YG; Shin SW; Kim SY; Kim S; Lim YT; Oh BK; Um SH
    Langmuir; 2019 Mar; 35(11):3992-3998. PubMed ID: 30844286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Harnessing nanoparticles for immune modulation.
    Getts DR; Shea LD; Miller SD; King NJ
    Trends Immunol; 2015 Jul; 36(7):419-27. PubMed ID: 26088391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment.
    Lang X; Wang X; Han M; Guo Y
    Int J Nanomedicine; 2024; 19():4533-4568. PubMed ID: 38799699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insight into extravasation and internalization of nanoparticles.
    Park K
    J Control Release; 2015 May; 206():243. PubMed ID: 25907318
    [No Abstract]   [Full Text] [Related]  

  • 34. Virosomes: evolution of the liposome as a targeted drug delivery system.
    Kaneda Y
    Adv Drug Deliv Rev; 2000 Sep; 43(2-3):197-205. PubMed ID: 10967226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Acidity/NIR Controlled Interaction of Transformable Nanoparticle with Biological Systems for Cancer Therapy.
    Li D; Ma Y; Du J; Tao W; Du X; Yang X; Wang J
    Nano Lett; 2017 May; 17(5):2871-2878. PubMed ID: 28375632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface loading of nanoparticles on engineered or natural erythrocytes for prolonged circulation time: strategies and applications.
    Zhang SQ; Fu Q; Zhang YJ; Pan JX; Zhang L; Zhang ZR; Liu ZM
    Acta Pharmacol Sin; 2021 Jul; 42(7):1040-1054. PubMed ID: 33772141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nano-based drug delivery system for therapeutics: a comprehensive review.
    Prakash S
    Biomed Phys Eng Express; 2023 Aug; 9(5):. PubMed ID: 37549657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients.
    Starling BR; Kumar P; Lucas AT; Barrow D; Farnan L; Hendrix L; Giovinazzo H; Song G; Gehrig P; Bensen JT; Zamboni WC
    Cancer Chemother Pharmacol; 2019 Jan; 83(1):61-70. PubMed ID: 30327876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticles and microparticles for skin drug delivery.
    Prow TW; Grice JE; Lin LL; Faye R; Butler M; Becker W; Wurm EM; Yoong C; Robertson TA; Soyer HP; Roberts MS
    Adv Drug Deliv Rev; 2011 May; 63(6):470-91. PubMed ID: 21315122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Friends or foes: The mononuclear phagocyte system in ischemic stroke.
    Ziqing Z; Yunpeng L; Yiqi L; Yang W
    Brain Pathol; 2023 Mar; 33(2):e13151. PubMed ID: 36755470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.